Patents by Inventor Minhong Yan

Minhong Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11999787
    Abstract: The invention provides Tie-2 antibodies and fragments thereof and conjugates and methods of using the same.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: June 4, 2024
    Assignee: Genentech, Inc.
    Inventors: Minhong Yan, Gu Zhang, Nicholas John Agard, Danielle Marie Dicara, Philip E. Hass, Julie Q. Hang, Erin L. Christensen, Robert Paul Morse, Sarah Sanowar, Vittal Shivva
  • Publication number: 20220135701
    Abstract: The present disclosure provides anti-MerTK antibodies and methods of use thereof. The methods comprise administering an anti-MerTK antibody or an immunoconjugate thereof.
    Type: Application
    Filed: October 13, 2021
    Publication date: May 5, 2022
    Applicant: Genentech, Inc.
    Inventors: Wei-Ching LIANG, WeiYu Lin, Yan Wu, Minhong Yan
  • Publication number: 20210332142
    Abstract: The invention provides Tie-2 antibodies and fragments thereof and conjugates and methods of using the same.
    Type: Application
    Filed: March 22, 2021
    Publication date: October 28, 2021
    Applicant: Genentech, Inc.
    Inventors: Minhong YAN, Gu ZHANG, Nicholas John AGARD, Danielle Marie DICARA, Philip E. HASS, Julie Q. HANG, Erin L. CHRISTENSEN, Robert Paul MORSE, Sarah SANOWAR, Vittal SHIVVA
  • Patent number: 9845354
    Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: February 25, 2016
    Date of Patent: December 19, 2017
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Minhong Yan
  • Publication number: 20170275359
    Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: July 15, 2015
    Publication date: September 28, 2017
    Inventors: Yan WU, Minhong YAN
  • Publication number: 20170029501
    Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: February 25, 2016
    Publication date: February 2, 2017
    Inventors: Yan WU, Minhong YAN
  • Patent number: 9249222
    Abstract: The invention provides anti-EphB4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: January 12, 2012
    Date of Patent: February 2, 2016
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Minhong Yan
  • Publication number: 20150250874
    Abstract: Disclosed herein are methods and compositions for treating disorders associated with angiogenesis or lymphangiogenesis using ALK-1 antagonists.
    Type: Application
    Filed: May 22, 2015
    Publication date: September 10, 2015
    Inventors: Minhong YAN, Gu ZHANG
  • Patent number: 9115191
    Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: June 4, 2012
    Date of Patent: August 25, 2015
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Minhong Yan
  • Patent number: 9066930
    Abstract: Disclosed herein are methods and compositions for treating disorders associated with angiogenesis or lymphangiogenesis using ALK-1 antagonists.
    Type: Grant
    Filed: May 20, 2011
    Date of Patent: June 30, 2015
    Assignee: Genentech, Inc.
    Inventors: Minhong Yan, Gu Zhang
  • Publication number: 20130143266
    Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: June 4, 2012
    Publication date: June 6, 2013
    Inventors: Yan Wu, Minhong Yan
  • Publication number: 20120207747
    Abstract: The invention provides anti-EphB4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: January 12, 2012
    Publication date: August 16, 2012
    Applicant: Genentech, Inc.
    Inventors: Yan WU, Minhong Yan
  • Publication number: 20120178163
    Abstract: The present invention is directed to novel polypeptides having homology to members of the tumor necrosis factor receptor family and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptides molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
    Type: Application
    Filed: January 6, 2012
    Publication date: July 12, 2012
    Inventors: Audrey Goddard, James Pan, Minhong Yan
  • Publication number: 20120171203
    Abstract: Disclosed herein are methods and compositions for treating disorders associated with angiogenesis or lymphangiogenesis using ALK-1 antagonists.
    Type: Application
    Filed: May 20, 2011
    Publication date: July 5, 2012
    Inventors: Minhong Yan, Gu Zhang
  • Patent number: 8197815
    Abstract: The invention provides anti-EphrinB2 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: January 19, 2007
    Date of Patent: June 12, 2012
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Minhong Yan
  • Patent number: 8101365
    Abstract: The invention provides anti-EphB4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: January 24, 2012
    Assignee: Genentech, Inc.
    Inventors: Yan Wu, Minhong Yan
  • Publication number: 20100292312
    Abstract: The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: August 2, 2010
    Publication date: November 18, 2010
    Applicant: Genentech, Inc.
    Inventors: Minhong Yan, Yan Wu
  • Patent number: 7803377
    Abstract: The invention provides anti-DLL4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Grant
    Filed: June 6, 2007
    Date of Patent: September 28, 2010
    Assignee: Genentech, Inc.
    Inventors: Minhong Yan, Yan Wu
  • Publication number: 20100129356
    Abstract: The present invention provides methods of using a DLL4 modulator to modulate vascular development. Furthermore, methods of treatment using DLL4 modulators, such as DLL4 antagonists, are provided.
    Type: Application
    Filed: July 2, 2009
    Publication date: May 27, 2010
    Applicant: GENENTECH, INC.
    Inventor: MINHONG YAN
  • Publication number: 20100015135
    Abstract: The invention provides anti-EphB4 antibodies, and compositions comprising and methods of using these antibodies.
    Type: Application
    Filed: January 4, 2007
    Publication date: January 21, 2010
    Applicant: Genentech, Inc.
    Inventors: Yan Wu, Minhong Yan